How apoptosis is regulated, and what goes wrong in cancer
How apoptosis is regulated, and what goes wrong in cancer
复制标题
DOI:
10.1136/bmj.322.7301.1538
复制
发表时间:
2001-06-23
影响因子:
--
通讯作者:
Bergh, J
中科院分区:
文献类型:
--
作者:
Sjöström, J;Bergh, J
Programmed cell death (apoptosis) is an evolutionarily conserved pathway needed for embryonic development and tissue homoeostasis. 1 Apoptosis is the normal physiological response to many stimuli, including irreparable DNA damage. Various diseases evolve because of hyperactivation (neurodegenerative diseases, immunodeficiency, ischaemia-reperfusion injury) or suppression of programmed cell death (cancer, autoimmune disorders). 2 In cancer, the balance between proliferation and programmed cell death is disturbed, and defects in apoptotic pathways allow cells with genetic abnormalities to survive. Most cytotoxic and hormonal treatments, as well as radiation, ultimately kill cancer cells by causing irreparable cellular damage that triggers apoptosis. Consequently, the efficacy of cancer treatments depends not only on the cellular damage they cause but also on the cell’s ability to respond to the damage by inducing apoptotic machinery. Accordingly, mutations in apoptotic pathways may result in resistance to drugs and radiation. Such mutations might serve as predictors of chemoresistance and, most importantly, as new treatment targets. Mitochondria and cell surface receptors mediate the two main pathways of apoptosis. 1 The mitochondrial pathway is thought to be important in response to cancer treatment and is mediated by bcl-2 family proteins. The final execution of cell death is performed by the caspase cascade, which is triggered by release of cytochrome C from mitochondria.